Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy by Janneke Schilp et al.
Schilp et al. BMC Nephrology 2014, 15:2
http://www.biomedcentral.com/1471-2369/15/2RESEARCH ARTICLE Open AccessGuideline adherence for identification and
hydration of high-risk hospital patients for
contrast-induced nephropathy
Janneke Schilp1*, Carolien de Blok1, Maaike Langelaan1, Peter Spreeuwenberg1 and Cordula Wagner1,2Abstract
Background: Contrast-induced nephropathy (CIN) is a common cause of acute renal failure in hospital patients. To
prevent CIN, identification and hydration of high-risk patients is important. Prevention of CIN by hydration of
high-risk patients was one of the themes to be implemented in the Dutch Hospital Patient Safety Program. This
study investigates to what extent high-risk patients are identified and hydrated before contrast administration.
Hospital-related and admission-related factors associated with the hydration of high-risk patients are identified.
Methods: The adherence to the guideline concerning identification and hydration of high-risk patients for CIN was
evaluated retrospectively in 4297 patient records between November 2011 and December 2012. A multilevel logistic
regression analysis was used to investigate the association between hospital-related and patient-related factors and
hydration.
Results: The mean percentage patients with a known estimated Glomerular Filtration Rate before contrast
administration was 96.4%. The mean percentage high-risk patients for CIN was 14.6%. The mean percentage
high-risk patients hydrated before contrast administration was 68.5% and was constant over time. Differences
between individual hospitals explained 19% of the variation in hydration. The estimated Glomerular Filtration Rate
value and admission department were statistically significantly associated with the execution of hydration.
Conclusion: The identification of high-risk patients was almost 100%, but the subsequent step in the prevention of
CIN is less performed, as only two third of the high-risk patients were hydrated before contrast administration. Large
variation between individual hospitals confirmed the difference in hospitals in correctly applying the guideline for
preventing CIN.
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Contrast-induced nephropathy (CIN) is the third most
common cause of acute renal failure in hospital patients
[1]. The incidence of CIN in the general population is
0.6% to 2.3% [2], but when focusing on specific high-risk
patients the incidence can increase to more than 40%
[3]. CIN is pre-eminently a condition that is potentially
suitable for prevention, because it is iatrogenic, its risk
factors are well-known and its timing is predictable [4].* Correspondence: j.schilp@nivel.nl
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reproduction in any medium, provided the orThere is no universally accepted definition of CIN, but it
is usually recognized by an acute deterioration in renal func-
tion 2 to 7 days after contrast administration in the absence
of an alternative cause of acute renal failure. The most com-
monly used definition of CIN is an increase in serum cre-
atinine (sCr) of >25% or >44.2 μmol/L (>0.5 mg/dL) within
3 days of intravascular contrast medium administration [5].
CIN has been shown to be associated with an in-
creased risk of prolonged hospital stay, increased risk of
nosocomial complications, potential need for dialysis,
increased health care costs and mortality [6,7]. Several
studies showed effective interventions to decrease the
risk for CIN [8,9]. Hydration of high-risk patients fortd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cepted appropriate and safe measure to prevent CIN [8].
The effect of hydration on the reduction of developing
CIN was shown in a few studies [10-15], but only two of
these studies included a control group [11,15].
In 2008, the national Dutch Hospital Patient Safety
Program (Safety Program) started to improve patient
safety and to reduce potentially preventable unintended
adverse events in Dutch hospitals [16]. The Safety Pro-
gram consisted of ten themes regarding patient safety
and for each safety theme a module with interventions
was developed to support hospitals with the implemen-
tation of interventions concerning this theme. Preven-
tion of CIN by hydration of high-risk patients was one
of the themes to be implemented. The module for pre-
vention of CIN was based on a national guideline and
supported the identification and hydration of high-risk
patients for CIN [17,18]. Implementation of guidelines
has been proposed to reduce inappropriate care, increase
clinical efficiency and better control of health care
spending [19,20].
To the best of the authors knowledge, it is unclear to
what extent the guideline for prevention of CIN is
followed by identification and hydration of patients at
high risk for CIN before contrast administration. Fur-
thermore, it is unknown whether factors related to hos-
pitals or admission can be identified whereby hydration
is more or less often performed. Only risk factors associ-
ated with the development of CIN [21,22] were investi-
gated in previous studies. Factors associated with the
subsequent step in the process of preventing CIN were
not investigated. Therefore, the aim of the present study
was to describe the adherence to the guideline for CIN
by evaluating the degree of identification of high-risk pa-
tients for CIN and the hydration of high-risk patients
during the final year of the Safety Program. Further-
more, in order to gain insight into the factors associated
with the hydration of high-risk patients both hospital-
related and admission-related factors were investigated.
Methods
Study design
The present study was part of an evaluation study of the
implementation of the Safety Program in the Netherlands
[16]. The evaluation study was a longitudinal retrospective
evaluation study, performed during the final year of the
Safety Program between November 2011 and December
2012 [23]. A representative sample (n = 38) of hospitals,
stratified by area and type of hospital, was drawn from the
total sample of 92 Dutch hospitals. The participating hospi-
tals were assigned to three of the ten themes. For each
theme, every 4 to 6 weeks a measurement was performed
by a trained research assistant during 1 year follow-up,
resulting in a total of 10 measurements in each hospital.Data for the present study was collected within 19 hospitals
(2 academic, 6 tertiary teaching and 11 general hospitals).
Every measurement, a random sample of 20–25 patient
records was drawn by the hospital from all adult patients
(≥18 y) who have had contrast administration in the month
before the measurement.
Guideline adherence to prevent CIN
The adherence to the guideline for preventing CIN was
determined by evaluating to what extent high-risk pa-
tients for CIN were identified and hydrated. The identifi-
cation of high-risk patients for CIN was evaluated by
checking in the record if the eGFR (estimated Glomeru-
lar Filtration Rate) was known before the contrast
administration took place. Following the guideline, the
eGFR should be calculated with the MDRD formula,
using information of the creatinine concentration, age
and sex [18]. The most recent measurement was used to
assess the eGFR value and to define whether the patient
was at high-risk for CIN, with a maximum durability of
the eGFR measurement of 12 months before contrast
administration. Following the module for CIN, three
categories were defined as high-risk group: 1) eGFR <
45 ml/min/1.73 m2; 2) eGFR < 60 ml/min/1.73 m2 and
diabetes mellitus; 3) eGFR < 60 ml/min/1.73 m2 and ≥2
risk factors. Risk factors included in the checklist were:
peripheral vascular disease, heart failure, age > 75 year,
anemia, symptomatic hypotension, contrast volume >
150 ml, decreased circulating volume, use of diuretics
and use of nephrotoxic drugs.
To assess hydration, it was checked in the record
whether the patient was hydrated with saline or sodium
bicarbonate before contrast administration. Besides
hydration, two other prevention measures are mentioned
in the guideline, including advising on medication and
reducing dose of contrast administration, but these pre-
vention measures were not evaluated in the present
study.
Potential factors associated with hydration
In order to obtain insight into factors associated with
hydration of high-risk patients (yes/no) before contrast
administration, we assessed both hospital-related character-
istics and patient-related characteristics. Hospital-related
characteristics were type of hospital (tertiary teaching, aca-
demic and general), size of the hospital (number of beds)
and admission department. The seven most listed admis-
sion departments were allocated: cardiology, urology,
internal medicine, surgery, pulmonology and gastroenter-
ology. Different categories were created for those patients
listed as day admission whereby no specific department
was mentioned, for those listed as not admitted (for
example outpatient clinic) or unknown admission, and a
category for other less listed departments (for example
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related characteristics were acuteness of admission (yes/
no), day admission (yes/no) and eGFR value at admission
(continuous).
Data analysis
The percentage patients with a known eGFR before con-
trast administration, the percentage high-risk patients,
and the percentage high-risk patients who were hydrated
were calculated. Descriptive analyses were performed to
compare the characteristics of the group at high risk and
the group not at high risk for CIN. Chi-square tests were
used to test the difference for dichotomous and categor-
ical variables, and t-tests were used to test the difference
for continuous variables.
A multilevel logistic analysis was conducted to analyze
the trend in hydration of high-risk patients. A two-level
multilevel structure was used, whereby the observations
were clustered within hospitals. Time was modeled by
adding ten indicator variables for the moments (remov-
ing the intercept from the model), trends were tested
using polynomial contrast (to the 4th order) to study
development over time. The intraclass correlation coeffi-
cient (ICC) was calculated to indicate the correlation of
the observations within the same hospital. An ICC of
20% was seen as moderate [24]. To assess the association
between both hospital-related and patient-related factors
and hydration separate multilevel logistic regression ana-
lyses were performed using hydration as dependent
variable and the explanatory factors as independent
variables. Categorical independent variables were analyzed
by adding separate indicator variables for the categories
to the model. In the second analyses the multilevel
association models were all corrected for age and sex.
Descriptive analyses were performed using Stata ver-
sion 12.1 and the multivariate analyses were executed
with MlwiN version 2.24.
Results
Patient characteristics
A total of 4297 patient records were included in the
evaluation study. Mean age was 65.4 (SD 13.9) years and
54% was male. The mean length of hospital stay was 3.6
(SD 10.7) days and 23% of the patients was acutely
admitted to the hospital.
The percentage of patients with a known eGFR before
contrast administration was 96.4% (n = 4141). The mean
eGFR in this sample was 66.6 ml/min/1.73 m2. A statis-
tically significant difference in known eGFR (p < 0.001)
was found between the hospital types. The percentage
patients with a known eGFR was 93.8% in academic hos-
pitals, 95.3% in tertiary teaching hospitals and 97.2% in
general hospitals. No statistically significant difference
(p = 0.06) was found between the hospital departments,ranging from 94.6% in “other” departments to 97.3% in
surgery, day admission and no admission/unknown
departments.
Following the criteria of the module, 627 of the 4141
patients (14.6%) were assessed as high-risk patients for
CIN (Table 1). Those at high risk were statistically sig-
nificantly older, less often admitted for one day, more
often acutely admitted, had a longer hospital stay, a
lower eGFR-value, and more risk factors (mainly high
age, use of nephrotoxic drugs/diuretics, heart failure,
diabetes mellitus and peripheral vascular disease).High-risk patients and hydration
Table 2 shows the percentage high-risk patients and
percentage hydrated high-risk patients in the hospital
admission departments. For the analysis of hydrated
high-risk patients, those with a missing value on hydra-
tion were excluded (n = 46), resulting in a sample of 581
patients. The mean percentage high-risk patients was
14.6%, and ranged between 7% in case of no admission/
unknown to 38% for day admission. The mean percent-
age hydrated high-risk patients was 68.5%, ranging from
36.9% in case of no admission/unknown to 94.4% at the
urology department.Multilevel analyses
Figure 1 shows the trend over time for hydration of
high-risk patients during the final year of the Safety
Program. No statistically significant trend (first to the
fourth-order multilevel) was found over the study
period. The multi-level analysis shows that 19% (ICC =
18,89) of the total variance in hydration was caused by
differences between individual hospitals.
All high-risk patients for whom hydration was known
were selected for the multilevel analysis for the associ-
ation between hospital-related factors and patient-
related factors and hydration, except those with missing
values for age or sex (n = 20), resulting in a sample of
561 patients.
The association between potential explanatory factors
and hydration was investigated. The eGFR value was not
linearly associated with hydration and was therefore cat-
egorized based on quartiles. Hospital type, hospital size,
day admission and acute admission were not associ-
ated with hydration. There was a negative association
between the department no admission/unknown and
hydration (Table 3), meaning that high-risk patients
not (or unknown) admitted were on average less often
hydrated compared to the reference department internal
medicine. The ICC was 33.31, meaning that 33% of the
total variance in the association between admission depart-
ments and hydration was caused by differences between
individual hospitals. The estimate remained statistically
Table 1 Characteristics of patients (not) at high risk for contrast-induced nephropathy
Characteristics Patients at high risk Patients not at high risk Pa
n = 627 n = 3514
Sex, % male 54.5 54.1 0.831
Age in years, mean (SD) 74.9 (9.5) 64.0 (13.7) < 0.001
Length of stay in days, mean (SD) 4.7 (8.6) 3.4 (11.1) 0.004
Day admission, % 32.4 39.2 0.005
Acute admission, % 27.7 22.1 0.002
eGFR in ml/min/1.73 m2, mean (SD) 44.0 (11.6) 70.6 (17.1) < 0.001
Risk factors for CIN, %
0 risk factors 1.1 42.0 < 0.001
1 risk factor 9.7 26.6
2 risk factors 31.3 15.8
≥3 risk factors 57.9 15.7
Diabetes mellitus 31.4 13.3 < 0.001
Peripheral vascular disease 20.4 9.6 < 0.001
Heart failure 39.2 19.9 < 0.001
Age > 75 year 52.3 18.8 < 0.001
Anemia 8.9 2.7 < 0.001
Symptomatic hypotension 1.6 0.5 0.002
Contrast volume > 150 ml 1.6 0.8 0.054
Decreased circulating volume 0.16 0.03 0.169
Use of diuretics 41.3 15.1 < 0.001
Use of nephrotoxic drugs 52.0 30.4 < 0.001
Abbreviations: CIN Contrast-induced nephropathy.
aTested by chi-square tests (categorical variables) or Student’s t-tests (continuous variables).
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slightly decreased to 32.38.
There was a negative association between a high eGFR
(53–60) and hydration (Table 4), meaning that high-risk
patients with a higher eGFR were less often hydrated com-















aBecause in 46 high-risk patients information was missing about hydration, the num
from the number of high-risk patients in the third column.
bSuch as neurology, gynecology, geriatrics, intensive care, orthopedics, radiology anDiscussion
The eGFR, used for defining high-risk patients for CIN,
was known in almost all patients (96%) undergoing
contrast administration in Dutch hospitals. However,
the subsequent step in the prevention of CIN was
performed in fewer patients, as only on average 69% ofrisk patients in hospital admission departments
High-risk patients Hydration high-risk patients
n (%) n (%)a
89 (24.0) 69 (81.2)
18 (26.5) 17 (94.4)
158 (17.8) 92 (63.5)
59 (19.7) 42 (85.7)
18 (15.1) 12 (80.0)
23 (10.5) 14 (63.6)
99 (37.9) 79 (82.3)
110 (6.7) 38 (36.9)
52 (12.3) 35 (72.9)
627 (14.6) 398 (68.5)
ber of high-risk patients used to calculate the percentage hydration differed
d oncology.
Figure 1 Trend of percentage hydrated high-risk
patients (n = 581).
Table 4 Multi-level analysis of the association between
eGFR value and hydration of high-risk patients (n = 561)
Model 1a Model 2b
Estimate (SE) Estimate (SE)
Fixed effects
Successful hydration (constant) 1.39 (0.34) 1.42 (0.35)
eGFR value
<38 ml/min/1.73 m2 Reference Reference
38-44 ml/min/1.73 m2 0.38 (0.36) 0.34 (0.37)
45-52 ml/min/1.73 m2 −0.50 (0.31) −0.51 (0.32)
53-60 ml/min/1.73 m2 −1.86 (0.31)*** −1.87 (0.31)***
Age patient - 0.02 (0.01)
Sex patient - −0.23 (0.21)
Random effects
ICC 24.00 23.77
Hospital level variance 1.04 (0.42)* 1.03 (0.42)*
eGFR estimated Glomerular Filtration Rate; ICC Intraclass
Correlation Coefficient.
aModel 1 included successful hydration + eGFR value.
bModel 2 included model 1 + patients age and sex.
*P < 0.05, ***P < 0.001.
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trast administration. Over the course of the evaluation
study in which the hospitals were expected to fully imple-
ment the Safety Program, there was no significant change
in the rate of hydration of high-risk patients. A reasonable
percentage of the total variance in hydration was caused byTable 3 Multi-level analysis of the association between
admission department and hydration of high-risk
patients (n = 561)
Model 1a Model 2b
Estimate (SE) Estimate (SE)
Fixed effects
Successful hydration (constant) 1.45 (0.45) 1.46 (0.44)
Admission department
Internal medicine Reference Reference
Urology 1.01 (1.15) 1.04 (1.16)
Cardiology −0.69 (0.40) −0.71 (0.40)
Surgery 0.77 (0.58) 0.67 (0.58)
Pulmonology 0.02 (0.84) 0.10 (0.85)
Gastroenterology −0.64 (0.60) −0.75 (0.60)
Day admission 0.13 (0.46) 0.16 (0.46)
No admission/unknown −2.73 (0.43)*** −2.71 (0.43)***
Other departments 0.36 (0.57) 0.39 (0.58)
Age patient 0.02 (0.01)
Sex patient −0.28 (0.22)
Random effects
ICC 33.31 33.38
Hospital level variance 1.64 (0.63)** 1.58 (0.61)**
ICC Intraclass Correlation Coefficient.
aModel 1 included successful hydration + admission department.
bModel 2 included model 1 + patients age and sex.
**P < 0.01, ***P < 0.001.differences between individual hospitals. Admission depart-
ment and eGFR value were statistically significantly associ-
ated with hydration, showing that those with a higher
eGFR were less often hydrated compared to those with a
lower eGFR value, and those not (or unknown) admitted
were on average less often hydrated compared to the in-
ternal medicine department.
This is the first study investigating associations be-
tween hospital-related and admission-related factors and
hydration of high-risk patients for CIN. If a patient was
not (or unknown) admitted, only one out of three high-
risk patients was hydrated. This low hydration rate
seems to be explained mainly by the lack of time when a
patient is visiting the hospital for one day, which was
mostly an outpatient clinic visit. If patients had to undergo
contrast administration acutely, there is insufficient time
for hydration. The Safety Program module advises to
hydrate these patients with a shortened hydration scheme
[18]. However, in this case we would have also expected
an association between acute admission and hydration.
Patients at high risk were more often acutely admitted,
but there was no difference in hydration between those
acutely admitted and those not acutely admitted. Further-
more, non-statistically significant those admitted for one
day were often hydrated. This seems to be the result of
the Safety Program, as outpatients at high-risk for CIN
scheduled for contrast administration would probably be
hydrated at the day admission department. As most day
admissions are planned, the eGFR measurement and
hydration can also be scheduled. Another possible explan-
ation for the differences between departments in general,
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the categorization of high-risk groups for CIN. For
example, different risk factors were included in a hospital
checklist and the definition of an abnormal eGFR can
differ between the hospitals. If a higher cut-off value for
eGFR was used by hospitals, this may explain why high-
risk patients with a lower eGFR were more often hydrated
compared to high-risk patients in the highest eGFR
category. In addition, hydration of patients with a very low
eGFR value can probably be seen as more urgent than
hydration of high-risk patients with an eGFR value just
below the cut-off point. However, the usefulness of hydrat-
ing lower risk patients for CIN (based on the absence of
diabetes mellitus, age > 65 year, sCr >1.4 mg/dl) to prevent
the incidence of CIN was suggested in a non-randomized
controlled trial [25].Strengths and limitations
A strength of this study was the large representative
sample of hospitals, which enables generalizability of
the results to the national hospital population. Because
of the large sample of patient records a distinction
could be made between different types of departments
and hospitals. However, this separation was only pos-
sible in the multi-level analysis with all measurements
together, because otherwise the numbers within one
measurement would be too small to perform separate
analyses.
As this study was a patient record review study, the
data was based on the information registered in the
patient records. A limitation of this study design was
that we only had information about the registered eGFR
value and risk factors mentioned in the record and we
did not know whether the hospital actually recognized
high-risk patients. Possibly, not all risk factors included
in the guideline are known when a physician applied
contrast administration. Furthermore, if hydration was
not registered in the patient record, we cannot be sure
that the hydration was executed but incorrectly regis-
tered in the report. However, if hydration was not regis-
tered, this information could similarly not be found by
other healthcare providers, which may have a negative
effect on patient safety caused by an increased risk of
under- or overtreatment. Information about hydration
was missing in 46 records of the 627 high-risk patients
(7%) and these patients had to be excluded from further
analysis. If it was unknown whether a patient was admit-
ted to the hospital (department category “no admission/
unknown”), it seems reasonable that more information
was lacking in the report. Finally, we only have informa-
tion about the identification and hydration of high-risk
patients and do not know to what extent CIN was truly
prevented in these patients.Future research and practice
The hydration of high-risk patients is part of the module
supporting the prevention of CIN and is based on national
guidelines with preventing methods for contrast medium
administration [17,18]. During the Safety Program discus-
sion arose about the necessity of hydration within high-
risk patients with specific contra-indications, because it
was argumented that pre-hydration of these patients may
be dangerous. Furthermore, a recent discussion paper
questioned the evidence for CIN caused by contrast ad-
ministration within patients with an eGFR > 30 ml/min
[26]. The authors stated that prevention of CIN by hydra-
tion increases the health care costs and is also a burden
for the patients because of longer hospital stay. However,
the effect of hydration in reducing CIN in high-risk pa-
tients was shown in several studies. Although most of
these studies did not include a control group [10,12-14],
two RCT’s were performed with a placebo group and
showed a statistically significant effect on reducing CIN
[11,15]. No information was available about the costs of
hydration and future studies should therefore focus more
on the costeffectiveness of hydration of high-risk patients.
In practice, there should be more uniformity in the
definition of high-risk patients. Our study showed a wide
variety between the participating hospitals in using the
national guidelines. There might be arguments to deviate
from the protocol if hydration is not desirable for some
reason, but it is important to argument and report these
exceptions. The importance of assessing the eGFR and
registration of the eGFR and subsequent interventions in
the record to prevent CIN should be emphasized.Conclusions
There is clearly attention for the identification of high-
risk patients for CIN, but the adherence to the subse-
quent step in the prevention of CIN was less often
performed, as only two thirds of the high-risk patients
were hydrated before contrast administration. Special
attention is needed for high-risk patients with a rela-
tively higher eGFR and not (or unknown) admitted
high-risk patients, as hydration was statistically signifi-
cantly less executed in these patients. Deviation of the
guidelines may be caused by lack of time and possibly by
the use of different criteria for high risk patient by the
hospitals. Registration of identification and hydration of
high-risk patients is important to give insight in the
preventive methods, the validity of possible deliberate
deviations and to facilitate the feedback of results to
health care providers.Abbreviations
CIN: Contrast-induced nephropathy; eGFR: estimated glomerular filtration
rate; sCr: serum creatinine.
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